Vincent Serra
Director de Operaciones en NEOVACS .
Cargos activos de Vincent Serra
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NEOVACS | Director Técnico/Científico/I+D | - | - |
| Director de Operaciones | - | - | |
| Director Ejecutivo | - | - | |
| BioSupport AG | Corporate Officer/Principal | - | - |
Historial de carrera de Vincent Serra
Antiguos cargos conocidos de Vincent Serra.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Director Ejecutivo | 01/08/2005 | 01/02/2014 |
| Director Técnico/Científico/I+D | 01/08/2005 | 01/02/2014 | |
| Fundador | 22/12/2009 | 01/02/2014 | |
Anosys, Inc.
 Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Corporate Officer/Principal | 03/01/1999 | 01/02/2005 |
| ABIVAX | Corporate Officer/Principal | - | - |
Formación de Vincent Serra.
| University of Grenoble | Doctorate Degree |
Estadísticas
Internacional
| Francia | 4 |
| Estados Unidos | 2 |
| 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NEOVACS | Health Technology |
| ABIVAX | Health Technology |
| Empresas privadas | 3 |
|---|---|
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Health Technology |
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
| BioSupport AG |
- Bolsa de valores
- Insiders
- Vincent Serra
- Experiencia
